Compare GENNEX LABORATORIES with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. vs DIVIS LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENNEX LAB. DIVIS LABORATORIES GENNEX LAB./
DIVIS LABORATORIES
 
P/E (TTM) x 23.3 50.3 46.4% View Chart
P/BV x 3.1 11.5 26.6% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 GENNEX LAB.   DIVIS LABORATORIES
EQUITY SHARE DATA
    GENNEX LAB.
Mar-21
DIVIS LABORATORIES
Mar-21
GENNEX LAB./
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs63,913 0.2%   
Low Rs21,824 0.1%   
Sales per share (Unadj.) Rs4.4262.5 1.7%  
Earnings per share (Unadj.) Rs0.374.7 0.4%  
Cash flow per share (Unadj.) Rs0.484.4 0.5%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Avg Dividend yield %00.7 0.0%  
Book value per share (Unadj.) Rs3.1350.1 0.9%  
Shares outstanding (eoy) m126.50265.47 47.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.910.9 8.2%   
Avg P/E ratio x12.338.4 32.2%  
P/CF ratio (eoy) x10.134.0 29.8%  
Price / Book Value ratio x1.38.2 15.3%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m498761,517 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m728,258 0.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m55669,694 0.8%  
Other income Rs m5627 0.8%   
Total revenues Rs m56270,321 0.8%   
Gross profit Rs m6228,611 0.2%  
Depreciation Rs m92,556 0.3%   
Interest Rs m721 35.4%   
Profit before tax Rs m5126,660 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m106,818 0.2%   
Profit after tax Rs m4019,843 0.2%  
Gross profit margin %11.141.1 27.0%  
Effective tax rate %20.225.6 79.1%   
Net profit margin %7.328.5 25.5%  
BALANCE SHEET DATA
Current assets Rs m37767,906 0.6%   
Current liabilities Rs m19017,284 1.1%   
Net working cap to sales %33.572.6 46.1%  
Current ratio x2.03.9 50.4%  
Inventory Days Days4710 489.6%  
Debtors Days Days58,680,596878 6,683,259.2%  
Net fixed assets Rs m21245,963 0.5%   
Share capital Rs m127531 23.8%   
"Free" reserves Rs m27192,415 0.3%   
Net worth Rs m39792,946 0.4%   
Long term debt Rs m00-   
Total assets Rs m589113,869 0.5%  
Interest coverage x7.81,270.5 0.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.6 154.4%   
Return on assets %8.117.4 46.5%  
Return on equity %10.221.3 47.6%  
Return on capital %14.628.7 50.9%  
Exports to sales %41.20-   
Imports to sales %4.418.8 23.1%   
Exports (fob) Rs m229NA-   
Imports (cif) Rs m2413,127 0.2%   
Fx inflow Rs m22958,877 0.4%   
Fx outflow Rs m2913,341 0.2%   
Net fx Rs m20145,536 0.4%   
CASH FLOW
From Operations Rs m-1419,469 -0.1%  
From Investments Rs mNA751 -0.0%  
From Financial Activity Rs m16-349 -4.6%  
Net Cashflow Rs m219,872 0.0%  

Share Holding

Indian Promoters % 22.1 52.0 42.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 37.0 -  
FIIs % 0.0 19.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 78.0 48.1 162.2%  
Shareholders   50,052 274,505 18.2%  
Pledged promoter(s) holding % 8.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENNEX LAB. With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Why Did Shares of Divi's Lab Rally Today? (Views On News)

Jun 10, 2021

The stock jumped 3.6% in intraday trade to hit its 52-week high.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GENNEX LAB. SHARE PRICE


Jan 24, 2022 (Close)

TRACK GENNEX LAB.

  • Track your investment in GENNEX LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GENNEX LAB. 8-QTR ANALYSIS

COMPARE GENNEX LAB. WITH

MARKET STATS